                         SEQUENCE LISTING

<110>  BIOHAVEN THERAPEUTICS LTD.
       KAZMIERSKI, WIESLAW
       BERBASOVA, TETYANA
       RASTELLI, LUCA
       IBEN, LAWRENCE G
       BAYDEN, ALEXANDER
       BUNIN, ANNA
       CONROY, SCOTT
 
<120>  TECHNOLOGIES FOR PREVENTING OR TREATING INFECTIONS

<130>  BHL0001PCT

<150>  63/146584
<151>  2021-02-06

<160>  109   

<170>  PatentIn version 3.5

<210>  1
<211>  85
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  TARGET BINDING MOEITY

<400>  1

Asp Glu Asp Leu Glu Glu Leu Glu Arg Leu Tyr Arg Lys Ala Glu Glu 
1               5                   10                  15      


Val Ala Lys Glu Ala Lys Asp Ala Ser Arg Arg Gly Asp Asp Glu Arg 
            20                  25                  30          


Ala Lys Glu Gln Met Glu Arg Ala Met Arg Leu Phe Asp Gln Val Phe 
        35                  40                  45              


Glu Leu Ala Gln Glu Leu Gln Glu Lys Gln Thr Asp Gly Asn Arg Gln 
    50                  55                  60                  


Lys Ala Thr His Leu Asp Lys Ala Val Lys Glu Ala Ala Asp Glu Leu 
65                  70                  75                  80  


Tyr Gln Arg Val Arg 
                85  


<210>  2
<211>  75
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  TARGET BINDING MOEITY

<400>  2

Glu Leu Glu Glu Gln Val Met His Val Leu Asp Gln Val Ser Glu Leu 
1               5                   10                  15      


Ala His Glu Leu Leu His Lys Leu Thr Gly Glu Glu Leu Glu Arg Ala 
            20                  25                  30          


Ala Tyr Phe Asn Trp Trp Ala Thr Glu Met Met Leu Glu Leu Ile Lys 
        35                  40                  45              


Ser Asp Asp Glu Arg Glu Ile Arg Glu Ile Glu Glu Glu Ala Arg Arg 
    50                  55                  60                  


Ile Leu Glu His Leu Glu Glu Leu Ala Arg Lys 
65                  70                  75  


<210>  3
<211>  56
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  TARGET BINDING MOEITY

<400>  3

Asp Lys Glu Trp Ile Leu Gln Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly His Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Tyr Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg 
    50                  55      


<210>  4
<211>  56
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  TARGET BINDING MOEITY

<400>  4

Asp Lys Glu Glu Ile Leu Asn Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly Asn Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Leu Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg 
    50                  55      


<210>  5
<211>  56
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  TARGET BINDING MOEITY

<400>  5

Ser Asp Asp Glu Asp Ser Val Arg Tyr Leu Leu Tyr Met Ala Glu Leu 
1               5                   10                  15      


Arg Tyr Glu Gln Gly Asn Pro Glu Lys Ala Lys Lys Ile Leu Glu Met 
            20                  25                  30          


Ala Glu Phe Ile Ala Lys Arg Asn Asn Asn Glu Glu Leu Glu Arg Leu 
        35                  40                  45              


Val Arg Glu Val Lys Lys Arg Leu 
    50                  55      


<210>  6
<211>  64
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  TARGET BINDING MOEITY

<400>  6

Asn Asp Asp Glu Leu His Met Leu Met Thr Asp Leu Val Tyr Glu Ala 
1               5                   10                  15      


Leu His Phe Ala Lys Asp Glu Glu Ile Lys Lys Arg Val Phe Gln Leu 
            20                  25                  30          


Phe Glu Leu Ala Asp Lys Ala Tyr Lys Asn Asn Asp Arg Gln Lys Leu 
        35                  40                  45              


Glu Lys Val Val Glu Glu Leu Lys Glu Leu Leu Glu Arg Leu Leu Ser 
    50                  55                  60                  


<210>  7
<211>  56
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  TARGET BINDING MOEITY

<400>  7

Gln Arg Glu Lys Arg Leu Lys Gln Leu Glu Met Leu Leu Glu Tyr Ala 
1               5                   10                  15      


Ile Glu Arg Asn Asp Pro Tyr Leu Met Phe Asp Val Ala Val Glu Met 
            20                  25                  30          


Leu Arg Leu Ala Glu Glu Asn Asn Asp Glu Arg Ile Ile Glu Arg Ala 
        35                  40                  45              


Lys Arg Ile Leu Glu Glu Tyr Glu 
    50                  55      


<210>  8
<211>  65
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  TARGET BINDING MOEITY

<400>  8

Ser Leu Glu Glu Leu Lys Glu Gln Val Lys Glu Leu Lys Lys Glu Leu 
1               5                   10                  15      


Ser Pro Glu Met Arg Arg Leu Ile Glu Glu Ala Leu Arg Phe Leu Glu 
            20                  25                  30          


Glu Gly Asn Pro Ala Met Ala Met Met Val Leu Ser Asp Leu Val Tyr 
        35                  40                  45              


Gln Leu Gly Asp Pro Arg Val Ile Asp Leu Tyr Met Leu Val Thr Lys 
    50                  55                  60                  


Thr 
65  


<210>  9
<211>  56
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  TARGET BINDING MOEITY

<400>  9

Asp Arg Glu Gln Arg Leu Val Arg Phe Leu Val Arg Leu Ala Ser Lys 
1               5                   10                  15      


Phe Asn Leu Ser Pro Glu Gln Ile Leu Gln Leu Phe Glu Val Leu Glu 
            20                  25                  30          


Glu Leu Leu Glu Arg Gly Val Ser Glu Glu Glu Ile Arg Lys Gln Leu 
        35                  40                  45              


Glu Glu Val Ala Lys Glu Leu Gly 
    50                  55      


<210>  10
<211>  57
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  TARGET BINDING MOEITY

<400>  10

Asp Asp Asp Ile Arg Tyr Leu Ile Tyr Met Ala Lys Leu Arg Leu Glu 
1               5                   10                  15      


Gln Gly Asn Pro Glu Glu Ala Glu Lys Val Leu Glu Met Ala Arg Phe 
            20                  25                  30          


Leu Ala Glu Arg Leu Gly Met Glu Glu Leu Leu Lys Glu Val Arg Glu 
        35                  40                  45              


Leu Leu Arg Lys Ile Glu Glu Leu Arg 
    50                  55          


<210>  11
<211>  65
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  TARGET BINDING MOEITY

<400>  11

Pro Ile Ile Glu Leu Leu Arg Glu Ala Lys Glu Lys Asn Asp Glu Phe 
1               5                   10                  15      


Ala Ile Ser Asp Ala Leu Tyr Leu Val Asn Glu Leu Leu Gln Arg Thr 
            20                  25                  30          


Gly Asp Pro Arg Leu Glu Glu Val Leu Tyr Leu Ile Trp Arg Ala Leu 
        35                  40                  45              


Lys Glu Lys Asp Pro Arg Leu Leu Asp Arg Ala Ile Glu Leu Phe Glu 
    50                  55                  60                  


Arg 
65  


<210>  12
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide unit

<400>  12

Ala Pro Ala Arg 
1               


<210>  13
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  peptide unit

<400>  13

Arg Ala Pro Ala 
1               


<210>  14
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unite


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  aromatic amino acid

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  any amino acid

<220>
<221>  misc_feature
<222>  (3)..(4)
<223>  positively charged amino acid

<400>  14

Xaa Xaa Xaa Xaa 
1               


<210>  15
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  unit peptide


<220>
<221>  misc_feature
<222>  (1)..(2)
<223>  positively charged amino acid

<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  any amino acid

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  aromatic amino acid

<400>  15

Xaa Xaa Xaa Xaa 
1               


<210>  16
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  unit peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  any positively charged amino acid

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  any aromatic amino acid

<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  any positively charged amino acid

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  any amino acid

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  any positively charged amino acid

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  any aromatic amino acid

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  any positively charged amino acid

<400>  16

Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5           


<210>  17
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  unit peptide


<220>
<221>  misc_feature
<222>  (1)..(2)
<223>  any positively charged amino acid

<220>
<221>  misc_feature
<222>  (3)..(4)
<223>  any aromatic amino acid

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  any positively charged amino acid

<400>  17

Xaa Xaa Xaa Xaa Xaa 
1               5   


<210>  18
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  unit peptide


<220>
<221>  misc_feature
<222>  (1)..(3)
<223>  any positively charged amino acid

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  any aromatic amino acid

<400>  18

Xaa Xaa Xaa Xaa 
1               


<210>  19
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  19

His Trp Arg Gly Trp Ala 
1               5       


<210>  20
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  20

Trp Gly Arg Arg 
1               


<210>  21
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  21

Arg Arg Gly Trp 
1               


<210>  22
<211>  8
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  22

Asn Lys Phe Arg Gly Lys Tyr Lys 
1               5               


<210>  23
<211>  8
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  23

Asn Arg Phe Arg Gly Lys Tyr Lys 
1               5               


<210>  24
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  24

Asn Ala Arg Lys Phe Tyr Lys 
1               5           


<210>  25
<211>  8
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  25

Asn Ala Arg Lys Phe Tyr Lys Gly 
1               5               


<210>  26
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  26

His Trp Arg Gly Trp Val 
1               5       


<210>  27
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  27

Lys His Phe Arg Asn Lys Asp 
1               5           


<210>  28
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  28

Arg His Arg Phe Asn Lys Asp 
1               5           


<210>  29
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  29

Arg Thr Tyr Lys 
1               


<210>  30
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  30

Glu Leu Val Trp 
1               


<210>  31
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  31

Gly Glu Leu Val Trp 
1               5   


<210>  32
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  32

Ala Trp His Leu Gly Glu Leu Val Trp 
1               5                   


<210>  33
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit

<400>  33

Ala Trp Asp Leu Gly Glu Leu Val Trp 
1               5                   


<210>  34
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  any amino acid residue comprising -COOH

<400>  34

Ala Trp Xaa Leu Gly Glu Leu Val Trp 
1               5                   


<210>  35
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  disulfid
<222>  (2)..(12)

<400>  35

Asp Cys Ala Trp His Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  36
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  disulfid
<222>  (2)..(12)

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  an amino acid residue comprising -COOH

<220>
<221>  BINDING
<222>  (5)..(5)
<223>  binding to another moiety

<400>  36

Asp Cys Ala Trp Xaa Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  37
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  disulfid
<222>  (2)..(12)

<400>  37

Asp Cys Ala Trp Asp Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  38
<211>  11
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  SITE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  SITE
<222>  (2)..(2)
<223>  L-amino acid

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  any amino acid residue comprising -COOH

<400>  38

Pro Pro Ala Trp Xaa Leu Gly Glu Leu Val Trp 
1               5                   10      


<210>  39
<211>  11
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  SITE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  SITE
<222>  (2)..(2)
<223>  L-amino acid

<400>  39

Pro Pro Ala Trp Asp Leu Gly Glu Leu Val Trp 
1               5                   10      


<210>  40
<211>  11
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  SITE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  SITE
<222>  (2)..(2)
<223>  L-amino acid

<400>  40

Pro Pro Ala Trp His Leu Gly Glu Leu Val Trp 
1               5                   10      


<210>  41
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  SITE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  SITE
<222>  (2)..(2)
<223>  L-amino acid

<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  any amino acid comprising -COOH

<400>  41

Pro Pro Asp Cys Ala Trp Xaa Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10                  15  


<210>  42
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  SITE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  SITE
<222>  (2)..(2)
<223>  L-amino acid

<220>
<221>  disulfid
<222>  (4)..(14)

<400>  42

Pro Pro Asp Cys Ala Trp His Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10                  15  


<210>  43
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  SITE
<222>  (1)..(1)
<223>  D-amino acid

<220>
<221>  SITE
<222>  (2)..(2)
<223>  L-amino acid

<220>
<221>  disulfid
<222>  (4)..(14)

<400>  43

Pro Pro Asp Cys Ala Trp Asp Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10                  15  


<210>  44
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  disulfid
<222>  (1)..(15)

<220>
<221>  disulfid
<222>  (3)..(13)

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  any amino acid residue comprising -COOH

<400>  44

Cys Asp Cys Ala Trp Xaa Leu Gly Glu Leu Val Trp Cys Thr Cys 
1               5                   10                  15  


<210>  45
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  disulfid
<222>  (1)..(15)

<220>
<221>  disulfid
<222>  (3)..(13)

<400>  45

Cys Asp Cys Ala Trp His Leu Gly Glu Leu Val Trp Cys Thr Cys 
1               5                   10                  15  


<210>  46
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  disulfid
<222>  (1)..(15)

<220>
<221>  disulfid
<222>  (3)..(13)

<400>  46

Cys Asp Cys Ala Trp Asp Leu Gly Glu Leu Val Trp Cys Thr Cys 
1               5                   10                  15  


<210>  47
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (2)..(12)

<220>
<221>  binding
<222>  (10)..(10)
<223>  any amino acid

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  X is an residue with COOH

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  X is an amino acid residue

<400>  47

Asp Cys Ala Trp His Leu Gly Glu Leu Xaa Trp Cys Thr 
1               5                   10              


<210>  48
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (2)..(12)

<220>
<221>  binding
<222>  (6)..(6)
<223>  any amino acid

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  antibody binding moiety

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  any amino acid residue

<400>  48

Asp Cys Ala Trp His Xaa Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  49
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (2)..(12)

<220>
<221>  binding
<222>  (8)..(8)
<223>  X is any amino acid

<220>
<221>  binding
<222>  (8)..(8)
<223>  antibody binding moiety

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  X is any amino acid

<400>  49

Asp Cys Ala Trp His Leu Gly Xaa Leu Val Trp Cys Thr 
1               5                   10              


<210>  50
<211>  33
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  Mod_Res
<222>  (33)..(33)
<223>  amidation

<400>  50

Phe Asn Met Gln Gln Gln Arg Arg Phe Tyr Glu Ala Leu His Asp Pro 
1               5                   10                  15      


Asn Leu Asn Glu Glu Gln Arg Asn Ala Lys Ile Lys Ser Ile Arg Asp 
            20                  25                  30          


Asp 
    


<210>  51
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (5)..(34)

<400>  51

Phe Asn Met Gln Cys Gln Arg Arg Phe Tyr Glu Ala Leu His Asp Pro 
1               5                   10                  15      


Asn Leu Asn Glu Glu Gln Arg Asn Ala Lys Ile Lys Ser Ile Arg Asp 
            20                  25                  30          


Asp Cys 
        


<210>  52
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (4)..(14)

<400>  52

Arg Gly Asn Cys Ala Tyr His Arg Gly Gln Leu Val Trp Cys Thr Tyr 
1               5                   10                  15      


His 
    


<210>  53
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  SITE
<222>  (8)..(8)
<223>  optional binding site

<400>  53

Arg Gly Asn Cys Ala Tyr His Lys Gly Gln Leu Val Trp Cys Thr Tyr 
1               5                   10                  15      


His 
    


<210>  54
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  SITE
<222>  (5)..(5)
<223>  optional binding site

<400>  54

Arg Gly Asn Cys Lys Tyr His Arg Gly Gln Leu Val Trp Cys Thr Tyr 
1               5                   10                  15      


His 
    


<210>  55
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  SITE
<222>  (10)..(10)
<223>  optional binding site

<400>  55

Arg Gly Asn Cys Ala Trp His Arg Gly Lys Leu Val Trp Cys Thr Tyr 
1               5                   10                  15      


His 
    


<210>  56
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  SITE
<222>  (5)..(5)
<223>  optional binding site

<400>  56

Arg Gly Asn Cys Lys Trp His Arg Gly Glu Leu Val Trp Cys Thr Tyr 
1               5                   10                  15      


His 
    


<210>  57
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  site
<222>  (5)..(5)
<223>  optional binding site

<400>  57

Arg Gly Asn Cys Lys Trp His Arg Gly Gln Leu Val Trp Cys Thr Tyr 
1               5                   10                  15      


His 
    


<210>  58
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  site
<222>  (5)..(5)
<223>  optional binding site

<400>  58

Arg Gly Asn Cys Lys Tyr His Leu Gly Glu Leu Val Trp Cys Thr Tyr 
1               5                   10                  15      


His 
    


<210>  59
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  site
<222>  (5)..(5)
<223>  optional binding site

<400>  59

Arg Gly Asn Cys Lys Tyr His Leu Gly Gln Leu Val Trp Cys Thr Tyr 
1               5                   10                  15      


His 
    


<210>  60
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (2)..(12)

<220>
<221>  site
<222>  (3)..(3)
<223>  optional binding site

<400>  60

Asp Cys Lys Trp His Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  61
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (2)..(12)

<220>
<221>  site
<222>  (3)..(3)
<223>  optional binding site

<400>  61

Asp Cys Lys Tyr His Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  62
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (2)..(12)

<220>
<221>  site
<222>  (3)..(3)
<223>  optional binding site

<400>  62

Asp Cys Lys Trp His Arg Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  63
<211>  13
<212>  PRT
<213>  artificial organism

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (2)..(12)

<220>
<221>  site
<222>  (3)..(3)
<223>  optional binding site

<400>  63

Asp Cys Lys Trp His Leu Gly Gln Leu Val Trp Cys Thr 
1               5                   10              


<210>  64
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (2)..(12)

<220>
<221>  site
<222>  (3)..(3)
<223>  optional binding site

<220>
<221>  site
<222>  (3)..(3)
<223>  optional binding site

<400>  64

Asp Cys Lys Tyr His Arg Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  65
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (2)..(12)

<220>
<221>  site
<222>  (3)..(3)
<223>  optional binding site

<400>  65

Asp Cys Lys Tyr His Leu Gly Gln Leu Val Trp Cys Thr 
1               5                   10              


<210>  66
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (2)..(12)

<220>
<221>  site
<222>  (3)..(3)
<223>  optional bindng site

<400>  66

Asp Cys Lys Trp His Arg Gly Gln Leu Val Trp Cys Thr 
1               5                   10              


<210>  67
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (2)..(12)

<220>
<221>  site
<222>  (3)..(3)
<223>  optional binding site

<400>  67

Asp Cys Lys Tyr His Arg Gly Gln Leu Val Trp Cys Thr 
1               5                   10              


<210>  68
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  site
<222>  (3)..(3)
<223>  optional binding site

<220>
<221>  disulfid
<222>  (5)..(34)

<400>  68

Phe Asn Lys Gln Cys Gln Arg Arg Phe Tyr Glu Ala Leu His Asp Pro 
1               5                   10                  15      


Asn Leu Asn Glu Glu Gln Arg Asn Ala Arg Ile Arg Ser Ile Arg Asp 
            20                  25                  30          


Asp Cys 
        


<210>  69
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (5)..(34)

<220>
<221>  site
<222>  (31)..(31)
<223>  optional binding site

<400>  69

Phe Asn Met Gln Cys Gln Arg Arg Phe Tyr Glu Ala Leu His Asp Pro 
1               5                   10                  15      


Asn Leu Asn Glu Glu Gln Arg Asn Ala Arg Ile Arg Ser Ile Lys Asp 
            20                  25                  30          


Asp Cys 
        


<210>  70
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  antibody binding moiety


<220>
<221>  disulfid
<222>  (5)..(34)

<220>
<221>  site
<222>  (20)..(20)
<223>  optional binding site

<400>  70

Phe Asn Met Gln Cys Gln Arg Arg Phe Tyr Glu Ala Leu His Asp Pro 
1               5                   10                  15      


Asn Leu Asn Lys Glu Gln Arg Asn Ala Arg Ile Arg Ser Ile Arg Asp 
            20                  25                  30          


Asp Cys 
        


<210>  71
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  disulfid
<222>  (5)..(34)

<400>  71

Phe Asn Met Gln Cys Gln Arg Arg Phe Tyr Glu Ala Leu His Asp Pro 
1               5                   10                  15      


Asn Leu Asn Glu Glu Gln Arg Asn Ala Arg Ile Arg Ser Ile Arg Asp 
            20                  25                  30          


Asp Cys 
        


<210>  72
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unite


<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  site
<222>  (15)..(15)
<223>  optional binding site

<400>  72

Arg Gly Asn Cys Ala Trp His Leu Gly Gln Leu Val Trp Cys Lys Tyr 
1               5                   10                  15      


His 
    


<210>  73
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide unit


<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  site
<222>  (15)..(15)
<223>  optional binding site

<400>  73

Arg Gly Asn Cys Ala Trp His Leu Gly Glu Leu Val Trp Cys Lys Tyr 
1               5                   10                  15      


His 
    


<210>  74
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unite


<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  site
<222>  (16)..(16)
<223>  optional binding site

<400>  74

Arg Gly Asn Cys Ala Tyr His Leu Gly Gln Leu Val Trp Cys Thr Lys 
1               5                   10                  15      


His 
    


<210>  75
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  site
<222>  (17)..(17)
<223>  optional binding site

<400>  75

Arg Gly Asn Cys Ala Tyr His Leu Gly Gln Leu Val Trp Cys Thr Tyr 
1               5                   10                  15      


Lys 
    


<210>  76
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  site
<222>  (16)..(16)
<223>  optional binding site

<400>  76

Arg Gly Asn Cys Ala Tyr His Arg Gly Gln Leu Val Trp Cys Thr Lys 
1               5                   10                  15      


His 
    


<210>  77
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  site
<222>  (1)..(1)
<223>  optional binding site

<220>
<221>  disulfid
<222>  (5)..(34)

<400>  77

Lys Asn Met Gln Cys Gln Arg Arg Phe Tyr Glu Ala Leu His Asp Pro 
1               5                   10                  15      


Asn Leu Asn Glu Glu Gln Arg Asn Ala Arg Ile Arg Ser Ile Arg Asp 
            20                  25                  30          


Asp Cys 
        


<210>  78
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  disulfid
<222>  (5)..(34)

<220>
<221>  site
<222>  (7)..(7)
<223>  optional binding site

<400>  78

Phe Asn Met Gln Cys Gln Lys Arg Phe Tyr Glu Ala Leu His Asp Pro 
1               5                   10                  15      


Asn Leu Asn Glu Glu Gln Arg Asn Ala Arg Ile Arg Ser Ile Arg Asp 
            20                  25                  30          


Asp Cys 
        


<210>  79
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  disulfid
<222>  (5)..(34)

<220>
<221>  site
<222>  (13)..(13)
<223>  optional binding site

<400>  79

Phe Asn Met Gln Cys Gln Arg Arg Phe Tyr Glu Ala Lys His Asp Pro 
1               5                   10                  15      


Asn Leu Asn Glu Glu Gln Arg Asn Ala Arg Ile Arg Ser Ile Arg Asp 
            20                  25                  30          


Asp Cys 
        


<210>  80
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unite


<220>
<221>  disulfid
<222>  (5)..(34)

<220>
<221>  site
<222>  (24)..(24)
<223>  optional binding site

<400>  80

Phe Asn Met Gln Cys Gln Arg Arg Phe Tyr Glu Ala Leu His Asp Pro 
1               5                   10                  15      


Asn Leu Asn Glu Glu Gln Arg Lys Ala Arg Ile Arg Ser Ile Arg Asp 
            20                  25                  30          


Asp Cys 
        


<210>  81
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  disulfid
<222>  (5)..(34)

<220>
<221>  site
<222>  (6)..(6)
<223>  optional binding site

<400>  81

Phe Asn Met Gln Cys Lys Arg Arg Phe Tyr Glu Ala Leu His Asp Pro 
1               5                   10                  15      


Asn Leu Asn Glu Glu Gln Arg Asn Ala Arg Ile Arg Ser Ile Arg Asp 
            20                  25                  30          


Asp Cys 
        


<210>  82
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  disulfid
<222>  (5)..(34)

<220>
<221>  site
<222>  (32)..(32)
<223>  optional binding site

<400>  82

Phe Asn Met Gln Cys Gln Arg Arg Phe Tyr Glu Ala Leu His Asp Pro 
1               5                   10                  15      


Asn Leu Asn Glu Glu Gln Arg Asn Ala Arg Ile Arg Ser Ile Arg Lys 
            20                  25                  30          


Asp Cys 
        


<210>  83
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide unit


<220>
<221>  Mod-Res
<222>  (1)..(1)
<223>  acetylation

<220>
<221>  disulfid
<222>  (4)..(14)

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  X is K or R

<400>  83

Gly Pro Asp Cys Ala Tyr His Xaa Gly Glu Leu Val Trp Cys Thr Phe 
1               5                   10                  15      


His 
    


<210>  84
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide tag

<400>  84

Gly Gly Gly Gly Gly 
1               5   


<210>  85
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide tag

<400>  85

Leu Pro Glu Thr Gly 
1               5   


<210>  86
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide tag


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  any amino acid

<400>  86

Leu Pro Xaa Thr Gly 
1               5   


<210>  87
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide tag


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  any amino acid

<220>
<221>  Non_Ter
<222>  (5)..(5)
<223>  any amino acid

<400>  87

Leu Pro Xaa Thr Gly 
1               5   


<210>  88
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide tag


<220>
<221>  Non_Ter
<222>  (5)..(5)

<400>  88

Leu Pro Glu Thr Gly 
1               5   


<210>  89
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  reactive group


<220>
<221>  misc_feature
<222>  (6)..(7)
<223>  any amino acid

<400>  89

Leu Pro Glu Thr Gly Xaa Xaa 
1               5           


<210>  90
<211>  43
<212>  PRT
<213>  artificial sequence

<220>
<223>  reactive group

<400>  90

Gly Gly Ser Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Gly Ser Gly 
1               5                   10                  15      


Gly Gly Gly Ser Leu Pro Glu Thr Gly Gly Gly Gly Ser Gly Gly Ser 
            20                  25                  30          


Ser His His His His His His His His His His 
        35                  40              


<210>  91
<211>  56
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Mod_Res
<222>  (1)..(1)
<223>  Acetylation

<220>
<221>  Mod_Res
<222>  (56)..(56)
<223>  Amidation

<400>  91

Asp Lys Glu Glu Ile Leu Asn Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly Asn Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Leu Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg 
    50                  55      


<210>  92
<211>  56
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Binding
<222>  (1)..(1)
<223>  Chemical group

<220>
<221>  Mod_Res
<222>  (56)..(56)
<223>  Amidation

<400>  92

Asp Lys Glu Glu Ile Leu Asn Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly Asn Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Leu Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg 
    50                  55      


<210>  93
<211>  56
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Mod_Res
<222>  (1)..(1)
<223>  Acetylation

<400>  93

Asp Lys Glu Trp Ile Leu Gln Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly His Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Tyr Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg 
    50                  55      


<210>  94
<211>  56
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Binding
<222>  (1)..(1)
<223>  Chemical group

<400>  94

Asp Lys Glu Trp Ile Leu Gln Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly His Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Tyr Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg 
    50                  55      


<210>  95
<211>  64
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Mod_Res
<222>  (1)..(1)
<223>  Acetylation

<400>  95

Asn Asp Asp Glu Leu His Met Leu Met Thr Asp Leu Val Tyr Glu Ala 
1               5                   10                  15      


Leu His Phe Ala Lys Asp Glu Glu Ile Lys Lys Arg Val Phe Gln Leu 
            20                  25                  30          


Phe Glu Leu Ala Asp Lys Ala Tyr Lys Asn Asn Asp Arg Gln Lys Leu 
        35                  40                  45              


Glu Lys Val Val Glu Glu Leu Lys Glu Leu Leu Glu Arg Leu Leu Ser 
    50                  55                  60                  


<210>  96
<211>  64
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Binding
<222>  (1)..(1)
<223>  Chemical group

<400>  96

Asn Asp Asp Glu Leu His Met Leu Met Thr Asp Leu Val Tyr Glu Ala 
1               5                   10                  15      


Leu His Phe Ala Lys Asp Glu Glu Ile Lys Lys Arg Val Phe Gln Leu 
            20                  25                  30          


Phe Glu Leu Ala Asp Lys Ala Tyr Lys Asn Asn Asp Arg Gln Lys Leu 
        35                  40                  45              


Glu Lys Val Val Glu Glu Leu Lys Glu Leu Leu Glu Arg Leu Leu Ser 
    50                  55                  60                  


<210>  97
<211>  56
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Mod_Res
<222>  (56)..(56)
<223>  Amidation

<400>  97

Asp Lys Glu Trp Ile Leu Gln Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly His Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Tyr Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg 
    50                  55      


<210>  98
<211>  56
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Mod_Res
<222>  (1)..(1)
<223>  Acetylation

<220>
<221>  Mod_Res
<222>  (56)..(56)
<223>  Amidation

<400>  98

Asp Lys Glu Trp Ile Leu Gln Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly His Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Tyr Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg 
    50                  55      


<210>  99
<211>  56
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Binding
<222>  (1)..(1)
<223>  Chemical group

<220>
<221>  Mod_Res
<222>  (56)..(56)
<223>  amidation

<400>  99

Asp Lys Glu Trp Ile Leu Gln Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly His Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Tyr Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg 
    50                  55      


<210>  100
<211>  64
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Mod_Res
<222>  (64)..(64)
<223>  Amidation

<400>  100

Asn Asp Asp Glu Leu His Met Leu Met Thr Asp Leu Val Tyr Glu Ala 
1               5                   10                  15      


Leu His Phe Ala Lys Asp Glu Glu Ile Lys Lys Arg Val Phe Gln Leu 
            20                  25                  30          


Phe Glu Leu Ala Asp Lys Ala Tyr Lys Asn Asn Asp Arg Gln Lys Leu 
        35                  40                  45              


Glu Lys Val Val Glu Glu Leu Lys Glu Leu Leu Glu Arg Leu Leu Ser 
    50                  55                  60                  


<210>  101
<211>  64
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Mod_Res
<222>  (1)..(1)
<223>  acetylation

<220>
<221>  Mod_Res
<222>  (64)..(64)
<223>  amidation

<400>  101

Asn Asp Asp Glu Leu His Met Leu Met Thr Asp Leu Val Tyr Glu Ala 
1               5                   10                  15      


Leu His Phe Ala Lys Asp Glu Glu Ile Lys Lys Arg Val Phe Gln Leu 
            20                  25                  30          


Phe Glu Leu Ala Asp Lys Ala Tyr Lys Asn Asn Asp Arg Gln Lys Leu 
        35                  40                  45              


Glu Lys Val Val Glu Glu Leu Lys Glu Leu Leu Glu Arg Leu Leu Ser 
    50                  55                  60                  


<210>  102
<211>  64
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Binding
<222>  (1)..(1)
<223>  Chemical group

<220>
<221>  Mod_Res
<222>  (64)..(64)
<223>  amidation

<400>  102

Asn Asp Asp Glu Leu His Met Leu Met Thr Asp Leu Val Tyr Glu Ala 
1               5                   10                  15      


Leu His Phe Ala Lys Asp Glu Glu Ile Lys Lys Arg Val Phe Gln Leu 
            20                  25                  30          


Phe Glu Leu Ala Asp Lys Ala Tyr Lys Asn Asn Asp Arg Gln Lys Leu 
        35                  40                  45              


Glu Lys Val Val Glu Glu Leu Lys Glu Leu Leu Glu Arg Leu Leu Ser 
    50                  55                  60                  


<210>  103
<211>  56
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Mod_Res
<222>  (1)..(1)
<223>  Acetylation

<220>
<221>  Binding
<222>  (56)..(56)
<223>  Chemical group

<400>  103

Asp Lys Glu Trp Ile Leu Gln Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly His Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Tyr Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg 
    50                  55      


<210>  104
<211>  56
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Binding
<222>  (56)..(56)
<223>  chemical group

<400>  104

Asp Lys Glu Trp Ile Leu Gln Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly His Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Tyr Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg 
    50                  55      


<210>  105
<211>  99
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  SITE
<222>  (57)..(99)
<223>  Reactive group

<400>  105

Asp Lys Glu Glu Ile Leu Asn Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly Asn Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Leu Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg Gly Gly Ser Glu Gln Lys Leu Ile 
    50                  55                  60                  


Ser Glu Glu Asp Leu Gly Ser Gly Gly Gly Gly Ser Leu Pro Glu Thr 
65                  70                  75                  80  


Gly Gly Gly Gly Ser Gly Gly Ser Ser His His His His His His His 
                85                  90                  95      


His His His 
            


<210>  106
<211>  107
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  Site
<222>  (65)..(107)
<223>  reactive group

<400>  106

Asn Asp Asp Glu Leu Leu Met Leu Val Thr Asp Leu Val Ala Glu Ala 
1               5                   10                  15      


Leu Leu Phe Ala Lys Asp Glu Glu Ile Lys Lys Arg Val Phe Thr Leu 
            20                  25                  30          


Phe Glu Leu Ala Asp Lys Ala Tyr Lys Asn Asn Asp Arg Asp Thr Leu 
        35                  40                  45              


Ser Lys Val Val Ser Glu Leu Lys Glu Leu Leu Glu Arg Leu Gln Ser 
    50                  55                  60                  


Gly Gly Ser Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Gly Ser Gly 
65                  70                  75                  80  


Gly Gly Gly Ser Leu Pro Glu Thr Gly Gly Gly Gly Ser Gly Gly Ser 
                85                  90                  95      


Ser His His His His His His His His His His 
            100                 105         


<210>  107
<211>  80
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  binding
<222>  (1)..(1)
<223>  Chemical group

<400>  107

Asp Lys Glu Glu Ile Leu Asn Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly Asn Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Leu Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg Gly Gly Ser Glu Gln Lys Leu Ile 
    50                  55                  60                  


Ser Glu Glu Asp Leu Gly Ser Gly Gly Gly Gly Ser Leu Pro Glu Thr 
65                  70                  75                  80  


<210>  108
<211>  88
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial compound


<220>
<221>  binding
<222>  (1)..(1)
<223>  Chemical group

<400>  108

Asn Asp Asp Glu Leu Leu Met Leu Val Thr Asp Leu Val Ala Glu Ala 
1               5                   10                  15      


Leu Leu Phe Ala Lys Asp Glu Glu Ile Lys Lys Arg Val Phe Thr Leu 
            20                  25                  30          


Phe Glu Leu Ala Asp Lys Ala Tyr Lys Asn Asn Asp Arg Asp Thr Leu 
        35                  40                  45              


Ser Lys Val Val Ser Glu Leu Lys Glu Leu Leu Glu Arg Leu Gln Ser 
    50                  55                  60                  


Gly Gly Ser Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Gly Ser Gly 
65                  70                  75                  80  


Gly Gly Gly Ser Leu Pro Glu Thr 
                85              


<210>  109
<211>  64
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide unit

<400>  109

Asn Asp Asp Glu Leu Leu Met Leu Val Thr Asp Leu Val Ala Glu Ala 
1               5                   10                  15      


Leu Leu Phe Ala Lys Asp Glu Glu Ile Lys Lys Arg Val Phe Thr Leu 
            20                  25                  30          


Phe Glu Leu Ala Asp Lys Ala Tyr Lys Asn Asn Asp Arg Asp Thr Leu 
        35                  40                  45              


Ser Lys Val Val Ser Glu Leu Lys Glu Leu Leu Glu Arg Leu Gln Ser 
    50                  55                  60                  


